Is phentermine safe long-term?

Not robustly characterised long-term. FDA approval is short-term. Cardiovascular concerns require monitoring.

Phentermine: An Honest Audit (2026)

What it claims

Phentermine is a generic sympathomimetic that suppresses appetite by increasing norepinephrine. FDA-approved for short-term (12-week) weight management. Often paired with topiramate (Qsymia) for longer use.

The mechanism

Sympathetic nervous system stimulation reduces appetite. Mechanism is similar to amphetamine-class drugs but typically less abusive. Produces modest weight loss via reduced intake.

What the research actually shows

Studies (Munro 1968, Hendricks 2014) show ~5-7% weight loss in 12-week courses. Long-term use is off-label but common; cardiovascular safety in long-term use is not robustly characterised. Tachycardia, insomnia, anxiety are common.¹²

Who it works for

Adults with moderate obesity who can't access GLP-1 drugs (cost, supply, insurance), as a short-term boost. Adults under physician supervision for time-limited weight management.

Who it fails

Adults with hypertension, anxiety disorders, cardiovascular disease, or eating-disorder history. Adults expecting long-term weight maintenance from a 12-week course.

The honest verdict

Phentermine is an old-line appetite suppressant with modest effect, real cardiovascular and psychiatric considerations, and short-term FDA approval. It's much weaker than GLP-1s. Useful as a short-term tool for some patients; not a long-term solution.

What to do instead

If GLP-1 is accessible, that's a stronger choice with better evidence. Otherwise, a structured lifestyle protocol with medical support.

Common misconceptions

Is phentermine safe long-term?: Not robustly characterised long-term. FDA approval is short-term. Cardiovascular concerns require monitoring.

References

1.Fothergill E et al. (2016). Persistent metabolic adaptation 6 years after 'The Biggest Loser' competition. Obesity. PubMed 27136388
2.Rosenbaum M, Leibel RL (2010). Adaptive thermogenesis in humans. International Journal of Obesity. PubMed 20840326